pembrolizumab
merck
['pembro', 'sclc', 'nsclc']
#asco23 abs#9000
pem + platinum +/- pembro for tki-resistant, egfrmt, #nsclc. lba released now! n=492 (245/247) pfs hr=0.8, p = 0.0122 os hr=0.84, p = 0.0362 following tki, addtion of pembro does not improve os 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl